Voloridge Investment Management
ETNB

Voloridge Investment Management’s 89bio ETNB Stock Holding History

Voloridge Investment Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-80,904
Closed -$599K – 1238
2024
Q3 		$599K Buy
+80,904
New +$680K ﹤0.01% 1069
2023
Q4 		– Sell
-175,624
Closed -$2.71M – 1247
2023
Q3 		$2.71M Sell
175,624
-128,064
-42% -$2.15M 0.01% 839
2023
Q2 		$5.75M Sell
303,688
-271,092
-47% -$4.76M 0.03% 621
2023
Q1 		$8.75M Buy
574,780
+521,740
+984% +$6.8M 0.04% 487
2022
Q4 		$675K Buy
+53,040
New +$477K ﹤0.01% 1224

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Voloridge Investment Management's ETNB Position: Q4 2024 in Review

Voloridge Investment Management sold out of 89bio (ETNB) in Q4 2024, closing a stake of 80,904 shares — an estimated $599K sold.

Voloridge Investment Management first reported a position in ETNB in Q4 2022 and held it in 5 quarters. The position peaked at $8.75M in Q1 2023. 155 funds tracked by Wall St. Rank hold ETNB as of Q4 2024.

  • Voloridge Investment Management reported no remaining 89bio position as of Q4 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 80,904 89bio shares in Q4 2024, an estimated $599K.
  • Voloridge Investment Management first reported a position in 89bio in Q4 2022 and held it in 5 quarters.
  • Voloridge Investment Management's 89bio position peaked at $8.75M in Q1 2023.
  • 155 funds tracked by Wall St. Rank held 89bio as of Q4 2024.

Based on Voloridge Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.